Symbols / ELUT
ELUT Chart
About
Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators; and CanGaroo, which mitigates complications derived from implantable electronic devices and shortcomings of synthetic envelopes. It also provides ProxiCor for cardiac tissue repair and pericardial closure; Tyke, an extracellular material that is used in the repair of cardiac structures for neonate and infant patients; and VasCure, a patch material used to repair or reconstruct the peripheral vasculature. In addition, the company offers SimpliDerm, which uses human acellular dermal matrices for tissue repair and reconstruction in various applications, such as sports medicine, hernia repair, trauma reconstruction, and breast reconstruction. It serves hospitals and healthcare facilities through its direct sales force, commercial partners, independent sales agents, and distributors. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 47.40M |
| Enterprise Value | 70.96M | Income | -25.30M | Sales | 21.75M |
| Book/sh | -1.03 | Cash/sh | 0.11 | Dividend Yield | — |
| Payout | 0.00% | Employees | 51 | IPO | — |
| P/E | — | Forward P/E | -1.01 | PEG | — |
| P/S | 2.18 | P/B | -1.08 | P/C | — |
| EV/EBITDA | -3.67 | EV/Sales | 3.26 | Quick Ratio | 0.20 |
| Current Ratio | 0.45 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.93 | EPS next Y | -1.10 | EPS Growth | — |
| Revenue Growth | -9.30% | Earnings | 2026-03-05 | ROA | -36.48% |
| ROE | — | ROIC | — | Gross Margin | 45.97% |
| Oper. Margin | -131.06% | Profit Margin | -121.73% | Shs Outstand | 40.35M |
| Shs Float | 24.85M | Short Float | 0.54% | Short Ratio | 0.38 |
| Short Interest | — | 52W High | 3.46 | 52W Low | 0.50 |
| Beta | 0.67 | Avg Volume | 381.28K | Volume | 45.43K |
| Target Price | $3.50 | Recom | None | Prev Close | $1.09 |
| Price | $1.11 | Change | 1.83% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$3.50
Mean price target
2. Current target
$1.11
Latest analyst target
3. DCF / Fair value
$-6.17
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.11
Low
$2.00
High
$5.00
Mean
$3.50
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-09-10 | main | Lake Street | Buy → Buy | $6 |
| 2025-05-09 | main | Lake Street | Buy → Buy | $8 |
| 2025-03-07 | reit | Cantor Fitzgerald | Overweight → Overweight | $8 |
| 2024-11-15 | reit | Cantor Fitzgerald | Overweight → Overweight | $10 |
| 2024-09-06 | reit | Cantor Fitzgerald | Overweight → Overweight | $10 |
| 2024-08-08 | main | Cantor Fitzgerald | Overweight → Overweight | $10 |
| 2024-06-21 | main | Lake Street | Buy → Buy | $10 |
| 2024-06-20 | main | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-06-18 | main | Cantor Fitzgerald | Overweight → Overweight | $11 |
| 2024-05-10 | main | Cantor Fitzgerald | Overweight → Overweight | $5 |
| 2023-11-14 | main | Cantor Fitzgerald | Overweight → Overweight | $6 |
| 2023-09-28 | init | Lake Street | — → Buy | $3 |
| 2023-09-26 | reit | Cantor Fitzgerald | Overweight → Overweight | $8 |
| 2023-09-19 | reit | Cantor Fitzgerald | Overweight → Overweight | $8 |
- Elutia Inc. (NASDAQ:ELUT) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st Sun, 15 Feb 2026 08
- Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround - Yahoo Finance Wed, 10 Sep 2025 07
- Insider Purchase: Director at $ELUT Buys 15,000 Shares - Quiver Quantitative hu, 29 Jan 2026 08
- Is Elutia Stock Built to Withstand More Downside? - Trefis Sun, 21 Dec 2025 08
- $88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan Wed, 01 Oct 2025 07
- Insider Purchase: Director at $ELUT Buys 15,500 Shares - Quiver Quantitative Wed, 19 Nov 2025 08
- ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance Wed, 31 Dec 2025 08
- Insider Buying: Guido Neels Acquires 30,000 Shares of Elutia Inc (ELUT) - GuruFocus hu, 29 Jan 2026 08
- Quarterly Earnings: Can US Physical Therapy Inc deliver consistent EPS growth - 2025 Earnings Impact & Breakout Confirmation Trade Signals - baoquankhu1.vn Wed, 25 Feb 2026 00
- Elutia Inc: director Neels buys $31.8k in company stock - Investing.com hu, 29 Jan 2026 08
- Elutia Loses US$4.6m Market Value But Insiders See Windfall Of US$60k - Sahm Fri, 06 Feb 2026 08
- Breast reconstruction infections hit 25% of patients. A new approach emerges - Stock Titan Fri, 09 Jan 2026 08
- US$6.50: That's What Analysts Think Elutia Inc. (NASDAQ:ELUT) Is Worth After Its Latest Results - simplywall.st ue, 19 Aug 2025 07
- Elutia Inc (ELUT) Q3 2025 Earnings Call Highlights: Strategic Growth and Financial Resilience - Yahoo Finance hu, 06 Nov 2025 08
- Elutia Second Quarter 2025 Earnings: Misses Expectations - simplywall.st Sat, 16 Aug 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 20000 | 20800.0 | — | Purchase at price 1.04 per share. | NEELS GUIDO J | Director | — | 2026-01-30 00:00:00 | D |
| 1 | 70000 | 74200.0 | — | Purchase at price 1.06 per share. | RAKIN KEVIN L | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-01-30 00:00:00 | D |
| 2 | 30000 | 31800.0 | — | Purchase at price 1.06 per share. | NEELS GUIDO J | Director | — | 2026-01-29 00:00:00 | D |
| 3 | 25000 | 13000.0 | — | Purchase at price 0.52 per share. | MAKES BRIGID A | Director | — | 2025-12-17 00:00:00 | D |
| 4 | 50000 | 25995.0 | — | Purchase at price 0.52 per share. | RAKIN KEVIN L | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-12-17 00:00:00 | I |
| 5 | 3000 | 1530.0 | — | Purchase at price 0.51 per share. | MILLS CHARLES RANDAL | Chief Executive Officer | — | 2025-12-17 00:00:00 | D |
| 6 | 60000 | 31800.0 | — | Purchase at price 0.53 per share. | FERGUSON MATTHEW B | Chief Financial Officer | — | 2025-12-17 00:00:00 | D |
| 7 | 12500 | 6375.0 | — | Purchase at price 0.51 per share. | COLPMAN DAVID | Director | — | 2025-12-17 00:00:00 | D |
| 8 | 27083 | nan | — | — | MILLS CHARLES RANDAL | Chief Executive Officer | — | 2025-12-10 00:00:00 | D |
| 9 | 12500 | nan | — | — | FERGUSON MATTHEW B | Chief Financial Officer | — | 2025-12-10 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -2.97M | -1.09M | -74.52K |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -19.65M | -17.55M | -22.10M | -15.45M |
| TotalUnusualItems | -26.25M | -14.13M | -5.20M | -276.00K |
| TotalUnusualItemsExcludingGoodwill | -26.25M | -14.13M | -5.20M | -276.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -54.13M | -41.25M | -36.18M | -24.83M |
| ReconciledDepreciation | 3.45M | 3.75M | 3.73M | 3.73M |
| ReconciledCostOfRevenue | 13.67M | 13.69M | 12.21M | 28.37M |
| EBITDA | -45.89M | -31.68M | -27.30M | -15.72M |
| EBIT | -49.34M | -35.42M | -31.03M | -19.45M |
| NetInterestIncome | -4.78M | -5.80M | -5.12M | -5.32M |
| InterestExpense | 4.78M | 5.80M | 5.12M | 5.32M |
| NormalizedIncome | -27.88M | -30.09M | -32.07M | -24.63M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -53.95M | -37.66M | -32.90M | -24.83M |
| TotalExpenses | 48.66M | 45.28M | 53.84M | 70.15M |
| TotalOperatingIncomeAsReported | -35.65M | -30.53M | -35.19M | -23.03M |
| DilutedAverageShares | 29.07M | 18.16M | 13.83M | 10.44M |
| BasicAverageShares | 29.07M | 18.16M | 13.83M | 10.44M |
| DilutedEPS | -1.86 | -2.07 | -2.38 | -2.38 |
| BasicEPS | -1.86 | -2.07 | -2.38 | -2.38 |
| DilutedNIAvailtoComStockholders | -53.95M | -37.66M | -32.90M | -24.83M |
| NetIncomeCommonStockholders | -53.95M | -37.66M | -32.90M | -24.83M |
| OtherunderPreferredStockDividend | 0.00 | |||
| NetIncome | -53.95M | -37.66M | -32.90M | -24.83M |
| NetIncomeIncludingNoncontrollingInterests | -53.95M | -37.66M | -32.90M | -24.83M |
| NetIncomeDiscontinuousOperations | 180.00K | 3.59M | 3.29M | |
| NetIncomeContinuousOperations | -54.13M | -41.25M | -36.18M | -24.83M |
| TaxProvision | 7.00K | 28.00K | 34.00K | 55.00K |
| PretaxIncome | -54.12M | -41.22M | -36.15M | -24.78M |
| OtherIncomeExpense | -25.06M | -14.89M | -1.04M | 3.30M |
| OtherNonOperatingIncomeExpenses | 1.19M | -759.00K | 4.16M | 3.58M |
| SpecialIncomeCharges | -11.37M | -9.99M | -5.20M | -276.00K |
| OtherSpecialCharges | 11.37M | 9.99M | 5.20M | 276.00K |
| GainOnSaleOfSecurity | -14.88M | -4.14M | ||
| NetNonOperatingInterestIncomeExpense | -4.78M | -5.80M | -5.12M | -5.32M |
| InterestExpenseNonOperating | 4.78M | 5.80M | 5.12M | 5.32M |
| OperatingIncome | -24.28M | -20.54M | -29.99M | -22.76M |
| OperatingExpense | 34.99M | 31.59M | 41.63M | 41.78M |
| ResearchAndDevelopment | 3.79M | 4.40M | 7.73M | 9.27M |
| SellingGeneralAndAdministration | 31.20M | 27.19M | 33.90M | 32.51M |
| SellingAndMarketingExpense | 12.55M | 13.09M | 17.85M | 18.82M |
| GeneralAndAdministrativeExpense | 18.66M | 14.10M | 16.05M | 13.69M |
| OtherGandA | 18.66M | 14.10M | 16.05M | 13.69M |
| GrossProfit | 10.71M | 11.05M | 11.64M | 19.02M |
| CostOfRevenue | 13.67M | 13.69M | 12.21M | 28.37M |
| TotalRevenue | 24.38M | 24.75M | 23.85M | 47.39M |
| OperatingRevenue | 24.38M | 24.75M | 23.85M | 47.39M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 35.21M | 23.20M | 16.14M | 13.56M |
| ShareIssued | 35.21M | 23.20M | 16.14M | 13.56M |
| NetDebt | 10.61M | 4.40M | 7.27M | |
| TotalDebt | 24.74M | 23.95M | 24.49M | 23.24M |
| TangibleBookValue | -54.53M | -50.27M | -20.10M | -4.95M |
| InvestedCapital | -22.41M | -14.92M | 19.23M | 36.75M |
| WorkingCapital | -11.62M | -11.78M | 8.08M | 21.43M |
| NetTangibleAssets | -54.53M | -50.27M | -20.10M | -4.95M |
| CapitalLeaseObligations | 883.00K | 275.00K | 232.00K | 5.00K |
| CommonStockEquity | -46.26M | -38.60M | -5.03M | 13.52M |
| TotalCapitalization | -23.66M | -18.24M | 19.23M | 23.93M |
| TotalEquityGrossMinorityInterest | -46.26M | -38.60M | -5.03M | 13.52M |
| StockholdersEquity | -46.26M | -38.60M | -5.03M | 13.52M |
| RetainedEarnings | -229.59M | -175.64M | -137.99M | -105.09M |
| AdditionalPaidInCapital | 183.30M | 137.02M | 132.94M | 118.60M |
| CapitalStock | 35.00K | 23.00K | 16.00K | 13.00K |
| CommonStock | 35.00K | 23.00K | 16.00K | 13.00K |
| TotalLiabilitiesNetMinorityInterest | 82.39M | 82.03M | 73.87M | 53.65M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 44.59M | 38.99M | 31.26M | 27.65M |
| OtherNonCurrentLiabilities | 5.49M | 5.88M | 6.04M | 17.24M |
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 956.00K | ||
| DerivativeProductLiabilities | 16.08M | 12.76M | 0.00 | |
| NonCurrentDeferredLiabilities | 698.00K | |||
| NonCurrentDeferredRevenue | 698.00K | |||
| LongTermDebtAndCapitalLeaseObligation | 23.03M | 20.36M | 24.26M | 10.41M |
| LongTermCapitalLeaseObligation | 423.00K | 0.00 | 956.00K | 0.00 |
| LongTermDebt | 22.60M | 20.36M | 24.26M | 10.41M |
| CurrentLiabilities | 37.80M | 43.04M | 42.62M | 26.00M |
| OtherCurrentLiabilities | 24.83M | 26.77M | 31.28M | 2.75M |
| CurrentDeferredLiabilities | 5.00K | |||
| CurrentDeferredRevenue | 5.00K | |||
| CurrentDebtAndCapitalLeaseObligation | 1.71M | 3.60M | 232.00K | 12.83M |
| CurrentCapitalLeaseObligation | 460.00K | 275.00K | 232.00K | 5.00K |
| CurrentDebt | 1.25M | 3.32M | 12.82M | |
| OtherCurrentBorrowings | 1.25M | 3.32M | 8.06M | |
| LineOfCredit | 0.00 | 4.76M | ||
| PayablesAndAccruedExpenses | 11.25M | 12.68M | 11.10M | 10.42M |
| CurrentAccruedExpenses | 7.10M | 9.48M | 8.83M | 6.38M |
| Payables | 4.15M | 3.19M | 2.27M | 4.05M |
| OtherPayable | 906.00K | 900.00K | 2.47M | |
| AccountsPayable | 4.15M | 3.19M | 1.37M | 1.58M |
| TotalAssets | 36.13M | 43.43M | 68.84M | 67.17M |
| TotalNonCurrentAssets | 9.96M | 12.18M | 18.14M | 19.74M |
| OtherNonCurrentAssets | 2.51M | 76.00K | ||
| GoodwillAndOtherIntangibleAssets | 8.27M | 11.67M | 15.07M | 18.47M |
| OtherIntangibleAssets | 8.27M | 11.67M | 15.07M | 18.47M |
| NetPPE | 1.68M | 504.00K | 565.00K | 1.28M |
| AccumulatedDepreciation | -634.00K | -581.00K | -585.00K | -4.44M |
| GrossPPE | 2.32M | 1.08M | 1.15M | 5.72M |
| Leases | 103.00K | 92.00K | 613.00K | 606.00K |
| OtherProperties | 1.93M | 713.00K | -680.00K | 3.93M |
| MachineryFurnitureEquipment | 281.00K | 280.00K | 1.22M | 1.18M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 26.17M | 31.25M | 50.70M | 47.43M |
| OtherCurrentAssets | 1.99M | 2.17M | 2.39M | 1.45M |
| AssetsHeldForSaleCurrent | 0.00 | 9.50M | ||
| RestrictedCash | 0.00 | 35.00K | ||
| PrepaidAssets | 1.45M | |||
| Inventory | 3.91M | 3.85M | 4.24M | 9.55M |
| FinishedGoods | 2.73M | 3.33M | 3.05M | 6.84M |
| WorkInProcess | 740.00K | 286.00K | 541.00K | 834.00K |
| RawMaterials | 440.00K | 242.00K | 652.00K | 1.88M |
| Receivables | 7.04M | 5.96M | 17.59M | 6.00M |
| OtherReceivables | 4.76M | 2.70M | 13.81M | |
| AccountsReceivable | 2.28M | 3.26M | 3.77M | 6.00M |
| AllowanceForDoubtfulAccountsReceivable | -600.00K | -700.00K | -100.00K | -100.00K |
| GrossAccountsReceivable | 2.88M | 3.96M | 3.87M | 6.10M |
| CashCashEquivalentsAndShortTermInvestments | 13.24M | 19.28M | 16.99M | 30.39M |
| CashAndCashEquivalents | 13.24M | 19.28M | 16.99M | 30.39M |
| CashFinancial | 16.99M | 30.39M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -23.31M | -22.11M | -21.97M | -15.81M |
| RepaymentOfDebt | 0.00 | -4.76M | -2.78M | |
| IssuanceOfDebt | 25.00M | 0.00 | ||
| IssuanceOfCapitalStock | 12.39M | 10.09M | 10.09M | 13.75M |
| CapitalExpenditure | -654.00K | -346.00K | -540.00K | -369.00K |
| InterestPaidSupplementalData | 5.29M | 2.32M | 5.48M | 4.98M |
| EndCashPosition | 13.24M | 19.28M | 16.99M | 30.43M |
| BeginningCashPosition | 19.28M | 16.99M | 30.43M | 39.53M |
| ChangesInCash | -6.04M | 2.29M | -13.44M | -9.10M |
| FinancingCashFlow | 17.09M | 9.84M | 8.54M | 6.71M |
| CashFlowFromContinuingFinancingActivities | 17.09M | 9.84M | 8.54M | 6.71M |
| NetOtherFinancingCharges | -9.18M | 1.49M | -3.57M | -2.75M |
| ProceedsFromStockOptionExercised | 15.89M | 219.00K | 395.00K | 234.00K |
| NetPreferredStockIssuance | 0.00 | |||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 12.39M | 10.09M | 10.09M | 13.75M |
| CommonStockIssuance | 12.39M | 10.09M | 10.09M | 13.75M |
| NetIssuancePaymentsOfDebt | -2.00M | -1.96M | 1.62M | -4.53M |
| NetShortTermDebtIssuance | 0.00 | -4.76M | -1.75M | |
| ShortTermDebtPayments | 0.00 | -4.76M | -1.75M | |
| NetLongTermDebtIssuance | -2.00M | -1.96M | 6.38M | -2.78M |
| LongTermDebtPayments | -18.61M | -2.78M | ||
| LongTermDebtIssuance | 25.00M | 0.00 | ||
| InvestingCashFlow | -474.00K | 14.21M | -540.00K | -369.00K |
| CashFlowFromContinuingInvestingActivities | -474.00K | 14.21M | -540.00K | -369.00K |
| NetBusinessPurchaseAndSale | 180.00K | 14.55M | 0.00 | |
| SaleOfBusiness | 180.00K | 14.55M | 0.00 | |
| CapitalExpenditureReported | -654.00K | -346.00K | -540.00K | -369.00K |
| OperatingCashFlow | -22.66M | -21.76M | -21.43M | -15.45M |
| CashFlowFromContinuingOperatingActivities | -22.66M | -21.76M | -21.43M | -15.45M |
| ChangeInWorkingCapital | 2.94M | 6.96M | 5.71M | 2.38M |
| ChangeInOtherWorkingCapital | -70.00K | -571.00K | -552.00K | |
| ChangeInOtherCurrentLiabilities | 4.94M | -2.41M | 16.79M | -380.00K |
| ChangeInPayablesAndAccruedExpense | -1.15M | -2.11M | 5.59M | -420.00K |
| ChangeInPrepaidAssets | 743.00K | 167.00K | -1.53M | 1.44M |
| ChangeInInventory | -58.00K | -609.00K | -498.00K | 563.00K |
| ChangeInReceivables | -1.54M | 11.92M | -14.65M | 1.17M |
| ChangesInAccountReceivables | 527.00K | 802.00K | -834.00K | 1.17M |
| OtherNonCashItems | 1.85M | 5.55M | -1.94M | 2.77M |
| StockBasedCompensation | 7.89M | 2.44M | 3.65M | 3.54M |
| AssetImpairmentCharge | 460.00K | 590.00K | 0.00 | |
| DepreciationAmortizationDepletion | 3.45M | 3.75M | 3.73M | 3.73M |
| DepreciationAndAmortization | 3.45M | 3.75M | 3.73M | 3.73M |
| OperatingGainsLosses | 14.70M | -3.39M | 311.00K | -3.03M |
| GainLossOnInvestmentSecurities | 14.88M | 4.14M | ||
| GainLossOnSaleOfBusiness | -180.00K | -7.53M | 0.00 | |
| NetIncomeFromContinuingOperations | -53.95M | -37.66M | -32.90M | -24.83M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ELUT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|